https://clinicaltrials.gov/ct2/show/NCT04456439?cond=MIS-C&draw=2&rank=1

Puts some pieces together .....so new Mesoblast trial Covid 19 announced July 2nd for children and adolescents

Now I may not be a rocket scientist but I can sum this one up succinctly .....

"there is no way they'd be doing this one on children and adolescents for Covid if they hadn't had very very promising results in their adult trial with those results showing minimal maybe even zero side effects....it's kids they cross all T's and dot all I's beforehand"

I'm taking that statement as fact ....as spoken by my mum this very morning .....who just happens to be a ultra experienced retired child and adolescent nurse specialist

	ClinicalTrials.gov Identifier: NCT04456439
1	Expanded Access Status: Available First Posted: July 2, 2020 Last Update Posted: July 2, 2020

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)

Detailed Description:

This intermediate-size expanded access protocol plans to treat approximately 50 children or adolescents, male and female, with MIS-C associated with COVID-19. Participants who are 2 months to 17 years of age, inclusive, will be enrolled at multiple clinical sites across the United States.